RÉSUMÉ
Observational data suggest a link between gut microbiota and immune-related vasculitis, but causality remains unclear. A bidirectional mendelian randomization study was conducted using public genome-wide data. The inverse-variance-weighted (IVW) method identified associations and addressed heterogeneity.Families Clostridiaceae 1 and Actinomycetaceae correlated positively with granulomatosis with polyangiitis risk, while classes Lentisphaeria and Melainabacteria, and families Lachnospiraceae and Streptococcaceae showed negative associations. Behçet's disease was positively associated with the risk of family Streptococcaceae abundance. And other several gut microbiota constituents were identified as potential risk factors for immune-related vasculitis. Furthermore, combining positive association results from the IVW analysis revealed numerous shared gut microbiota constituents associated with immune-related vasculitis. MR analysis demonstrated a causal association between the gut microbiota and immune-related vasculitis, offering valuable insights for subsequent mechanistic and clinical investigations into microbiota-mediated immune-related vasculitis.
Sujet(s)
Microbiome gastro-intestinal , Analyse de randomisation mendélienne , Vascularite , Humains , Vascularite/microbiologie , Vascularite/immunologie , Vascularite/génétique , Étude d'association pangénomique , Facteurs de risqueRÉSUMÉ
The Foix-Alajouanine syndrome was originally reported by these authors in 1926, as rapidly progressive vasculitis on the background of a viral infection. The pathology was represented by the huge, more than 10 times, dilation either of the lumen, or the walls of the spinal vessels, either of the arteries, or the veins. There were no signs of thrombosis, no malformations. Massive necrosis was observed in the spinal cord. Though plenty of observations of the syndrome were reported over the past 100 years, most of them deal with arteriovenous malformations and/or thrombosis, which had not been revealed originally. We present the case of spinal viral vasculitis detected by means of spinal MR-angiography. The undoubted viral etiology of vasculitis allows us to attribute this observation to Foix-Alajouanine syndrome.
Sujet(s)
Angiographie par résonance magnétique , Moelle spinale , Humains , Syndrome , Moelle spinale/imagerie diagnostique , Moelle spinale/anatomopathologie , Vascularite/imagerie diagnostique , Vascularite/diagnostic , Mâle , FemelleRÉSUMÉ
Disease-monitoring in large vessel vasculitis (LVV) is challenging. Simultaneous 18F-fluorodeoxyglucose positron emission tomography with magnetic resonance imaging (PET/MRI) provides functional assessment of vascular inflammation alongside high-definition structural imaging with a relatively low burden of radiation exposure. Here, we investigate the ability of PET/MRI to monitor LVV disease activity longitudinally in a prospective cohort of patients with active LVV. We demonstrate that both the PET and MRI components of the scan can distinguish active from inactive disease using established quantification methods. Using logistic-regression modelling of PET/MRI metrics, we devise a novel PET/MRI-specific Vasculitis Activity using MR PET (VAMP) score which is able to distinguish active from inactive disease with more accuracy than established methods and detects changes in disease activity longitudinally. These findings are evaluated in an independent validation cohort. Finally, PET/MRI improves clinicians' assessment of LVV disease activity and confidence in disease management, as assessed via clinician survey. In summary, PET/MRI may be useful in tracking disease activity and assessing treatment-response in LVV. Based on our findings, larger, prospective studies assessing PET/MRI in LVV are now warranted.
Sujet(s)
Fluorodésoxyglucose F18 , Imagerie par résonance magnétique , Tomographie par émission de positons , Humains , Tomographie par émission de positons/méthodes , Imagerie par résonance magnétique/méthodes , Femelle , Mâle , Adulte d'âge moyen , Études prospectives , Sujet âgé , Adulte , Vascularite/imagerie diagnostique , Radiopharmaceutiques , Imagerie multimodale/méthodesRÉSUMÉ
OBJECTIVES: To evaluate the various skin conditions diagnosed in intensive care unit (ICU) patients. METHODS: This is a descriptive retrospective study of all adults, pediatric, and neonatal patients who were admitted to the ICU and had a dermatological manifestation during hospital stay or patients who had dermatological condition that requires ICU admission. All skin conditions were categorized and analyzed. RESULTS: A total of 344 ICU patients with 365 different dermatological conditions were included in the study. The age of patients ranged from less than 1-96 years, with a mean age of 43.6±30.1 years. Of the patients, 189 (54.9%) were males. The top 3 general disease categories observed were skin infections, inflammatory and autoimmune diseases, and drug reactions. The most commonly reported dermatological disorders included morbilliform drug eruption (6.8%), contact dermatitis (6.3%), vasculitis (5.5%), herpes zoster (4.6%), purpura due to thrombocytopenia (3.8%), dermatitis/eczema (3.8%), candidiasis (3.8%), infantile hemangioma (2.7%), unclassified drug reaction (2.5%), intertrigo (2.5%), and herpes simplex virus (2.5%). CONCLUSION: Dermatological disorders can occur at various levels of severity in the ICU. Skin infections, inflammatory and autoimmune diseases, and drug reactions were found to be the most prevalent conditions.
Sujet(s)
Unités de soins intensifs , Maladies de la peau , Centres de soins tertiaires , Humains , Arabie saoudite/épidémiologie , Mâle , Femelle , Adulte , Maladies de la peau/épidémiologie , Enfant , Adulte d'âge moyen , Adolescent , Unités de soins intensifs/statistiques et données numériques , Études rétrospectives , Nourrisson , Sujet âgé , Enfant d'âge préscolaire , Jeune adulte , Sujet âgé de 80 ans ou plus , Toxidermies/épidémiologie , Toxidermies/étiologie , Infections de la peau/épidémiologie , Vascularite/épidémiologie , Hémangiome/épidémiologie , Zona/épidémiologie , Eczéma de contact/épidémiologie , Eczéma de contact/étiologie , Maladies auto-immunes/épidémiologie , Nouveau-né , Candidose/épidémiologie , Thrombopénie/épidémiologieRÉSUMÉ
Infective endocarditis is a rare but life-threatening condition, occasionally linked to diverse immunologic manifestations, including mixed cryoglobulinemia. This can lead to cryoglobulinemic vasculitis, which has the potential for widespread organ damage. Although some cases have highlighted the relationship between infective endocarditis and cryoglobulinemic vasculitis, no comprehensive epidemiological evaluation or optimal treatment strategies have been advanced for such a combination. We present a case of methicillin-sensitive Staphylococcus aureus infective endocarditis associated with cryoglobulinemic vasculitis and conduct a literature review to compare management and outcomes in similar cases. Our patient presented with classical Meltzer's triad and mild renal involvement. Cryoimmunofixation confirmed type III cryoglobulinemia, and serum cytokines showed elevated IL-6 levels. The differential diagnosis included infective endocarditis and chronic active hepatitis C virus infection. Rapid symptom resolution after antibiotic treatment identified infective endocarditis as the likely cause of cryoglobulinemic vasculitis. Our case and review of the literature highlight that early identification of the cause of cryoglobulinemic vasculitis is crucial for selecting appropriate treatment and preventing recurrence or morbidity.
Sujet(s)
Co-infection , Cryoglobulinémie , Endocardite bactérienne , Hépatite C chronique , Infections à staphylocoques , Staphylococcus aureus , Vascularite , Humains , Cryoglobulinémie/étiologie , Cryoglobulinémie/complications , Cryoglobulinémie/diagnostic , Infections à staphylocoques/complications , Hépatite C chronique/complications , Vascularite/étiologie , Endocardite bactérienne/complications , Endocardite bactérienne/diagnostic , Endocardite bactérienne/étiologie , Mâle , Adulte d'âge moyen , Hepacivirus , Antibactériens/usage thérapeutiqueSujet(s)
Éosinophilie , Humains , Mâle , Femelle , Adulte d'âge moyen , Éosinophilie/diagnostic , Adulte , Vascularite/diagnostic , Sujet âgéRÉSUMÉ
Mixed cryoglobulinemia vasculitis (MCV) is caused in ~90% of cases by chronic hepatitis C virus (HCVposMCV) and more rarely by hepatitis B virus (HBV) infection, or apparently noninfectious. HCVposMCV develops in only ~5% of patients with chronic hepatitis C (CHC), but risk factors other than female gender have not been identified so far. We conducted a retrospective case control study investigating whether past active HBV infection, defined by hepatitis B surface antigen (HBsAg) seroclearance and anti-core antibody (HBcAb) positivity, could be a risk factor for developing HCVposMCV. The prevalence of HBsAg seroclearance was 48% within 123 HCVposMCV patients and 29% within 257 CHC patients (p=0.0003). Multiple logistic regression including as variables gender, birth year, age at HBV testing, cirrhosis, and hepatocellular carcinoma, confirmed an association of HBsAg seroclearance with HCVposMCV [adjusted odds ratio (OR) 2.82, 95% confidence interval (95% CI) 1.73-4.59, p<0.0001]. Stratification by gender, however, showed that HBsAg seroclearance was associated with HCVposMCV in male [OR 4.63, 95% CI 2.27-9.48, p<0.0001] and not in female patients [OR 1.85, 95% 95% CI 0.94-3.66, p=0.076]. HBsAg seroclearance, and more likely occult HBV infection, is an independent risk factor for HCVposMCV in male CHC patients.
Sujet(s)
Cryoglobulinémie , Antigènes de surface du virus de l'hépatite B , Hépatite C chronique , Vascularite , Humains , Mâle , Cryoglobulinémie/immunologie , Cryoglobulinémie/étiologie , Cryoglobulinémie/sang , Adulte d'âge moyen , Antigènes de surface du virus de l'hépatite B/sang , Antigènes de surface du virus de l'hépatite B/immunologie , Hépatite C chronique/complications , Hépatite C chronique/immunologie , Études rétrospectives , Facteurs de risque , Femelle , Sujet âgé , Vascularite/immunologie , Vascularite/épidémiologie , Vascularite/étiologie , Hépatite B/complications , Hépatite B/immunologie , Hépatite B/épidémiologie , Études cas-témoins , Virus de l'hépatite B/immunologie , Adulte , Facteurs sexuels , Hepacivirus/immunologieRÉSUMÉ
BACKGROUND: The standard treatment for Kawasaki disease is immunoglobulin therapy, but the high frequency of coronary sequelae in immunoglobulin-refractory cases indicates a need for further improvement in treatment. METHODS: Kawasaki disease-like vasculitis was induced in 5-week-old DBA/2 mice by intraperitoneal administration of 0.5 mg Candida albicans water-soluble fraction (CAWS) daily for 5 days followed by daily administration of candesartan, an angiotensin receptor blocker. The vasculitis suppression effect was confirmed histologically and serologically in mice sacrificed at 28 days after the start of candesartan. RESULTS: The area of inflammatory cell infiltration at the aortic root was 2.4±1.4% in the Control group, 18.1±1.9% in the CAWS group, and 7.1±2.3%, 5.8±1.4%, 7.6±2.4%, and 7.9±5.0% in the CAWS+candesartan 0.125-mg/kg, 0.25-mg/kg, 0.5-mg/kg, and 1.0-mg/kg groups, respectively (p=0.0200, p=0.0122, p=0.0122, and p=0.0200 vs. CAWS, respectively). The low-dose candesartan group also showed significantly reduced inflammatory cell infiltration. A similar trend was confirmed by immunostaining of macrophages and TGFß receptors. Measurement of the inflammatory cytokines IL-1ß, IL-6, and TNF-α confirmed the anti-vasculitis effect of candesartan. CONCLUSIONS: Candesartan inhibited vasculitis even at clinical doses used in children, making it a strong future candidate as an additional treatment for immunoglobulin-refractory Kawasaki disease.
Sujet(s)
Benzimidazoles , Dérivés du biphényle , Candida albicans , Modèles animaux de maladie humaine , Maladie de Kawasaki , Tétrazoles , Animaux , Benzimidazoles/pharmacologie , Benzimidazoles/administration et posologie , Maladie de Kawasaki/traitement médicamenteux , Tétrazoles/pharmacologie , Tétrazoles/administration et posologie , Candida albicans/effets des médicaments et des substances chimiques , Dérivés du biphényle/pharmacologie , Antagonistes du récepteur de type 1 de l'angiotensine-II/pharmacologie , Antagonistes du récepteur de type 1 de l'angiotensine-II/administration et posologie , Souris de lignée DBA , Solubilité , Eau , Vascularite/traitement médicamenteux , Mâle , Souris , Cytokines/métabolisme , Interleukine-6/métabolismeRÉSUMÉ
Endothelial cell injury is a hallmark of IgA vasculitis (IgAV), possibly associated with various factors, including oxidative stress. Certain single nucleotide polymorphisms (SNPs) of glutathione S-transferases (GST) genes have been shown to increase susceptibility to oxidative stress. The objective of our study was to evaluate the gene polymorphisms of GSTM1, GSTT1, GSTP1, and GSTA1 in patients with IgAV. DNA was extracted from the blood of 124 children with IgAV and 168 age-matched healthy controls. A higher frequency of the GSTM1 null genotype was observed in patients with gastrointestinal (GI) system involvement compared to those without GI system involvement (51.5% vs. 28.6%, p = 0.011). Additionally, the GSTM1 null genotype was less prevalent (30.8% vs. 69.2%, p = 0.032), while the GSTP1 Val/Val genotype was significantly more prevalent in patients who developed urogenital complications (scrotal swelling) during the course of the disease (60% vs. 40%, p = 0.039). This study is the first to suggest an association between GSTM1 and GSTP1 polymorphisms and various phenotypes observed during the clinical course of IgAV in the pediatric population. However, it was performed on a national and likely single ethnic cohort, too small for definitive conclusions, so larger studies are needed to confirm this association.
Sujet(s)
Prédisposition génétique à une maladie , Glutathione S-transferase pi , Glutathione transferase , , Polymorphisme de nucléotide simple , Adolescent , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Études cas-témoins , Fréquence d'allèle , Études d'associations génétiques , Génotype , Glutathione S-transferase pi/génétique , Glutathione transferase/génétique , /génétique , Immunoglobuline A/sang , Vascularite/génétiqueRÉSUMÉ
Background: Kawasaki disease (KD), an acute febrile illness and systemic vasculitis, is the leading cause of acquired heart disease in children in industrialized countries. KD leads to the development of coronary artery aneurysms (CAA) in affected children, which may persist for months and even years after the acute phase of the disease. There is an unmet need to characterize the immune and pathological mechanisms of the long-term complications of KD. Methods: We examined cardiovascular complications in the Lactobacillus casei cell wall extract (LCWE) mouse model of KD-like vasculitis over 4 months. The long-term immune, pathological, and functional changes occurring in cardiovascular lesions were characterized by histological examination, flow cytometric analysis, immunofluorescent staining of cardiovascular tissues, and transthoracic echocardiogram. Results: CAA and abdominal aorta dilations were detected up to 16 weeks following LCWE injection and initiation of acute vasculitis. We observed alterations in the composition of circulating immune cell profiles, such as increased monocyte frequencies in the acute phase of the disease and higher counts of neutrophils. We determined a positive correlation between circulating neutrophil and inflammatory monocyte counts and the severity of cardiovascular lesions early after LCWE injection. LCWE-induced KD-like vasculitis was associated with myocarditis and myocardial dysfunction, characterized by diminished ejection fraction and left ventricular remodeling, which worsened over time. We observed extensive fibrosis within the inflamed cardiac tissue early in the disease and myocardial fibrosis in later stages. Conclusion: Our findings indicate that increased circulating neutrophil counts in the acute phase are a reliable predictor of cardiovascular inflammation severity in LCWE-injected mice. Furthermore, long-term cardiac complications stemming from inflammatory cell infiltrations in the aortic root and coronary arteries, myocardial dysfunction, and myocardial fibrosis persist over long periods and are still detected up to 16 weeks after LCWE injection.
Sujet(s)
Paroi cellulaire , Modèles animaux de maladie humaine , Fibrose , Lacticaseibacillus casei , Maladie de Kawasaki , Vascularite , Animaux , Souris , Paroi cellulaire/immunologie , Vascularite/immunologie , Vascularite/étiologie , Vascularite/anatomopathologie , Maladie de Kawasaki/immunologie , Maladie de Kawasaki/complications , Mâle , Myocardite/étiologie , Myocardite/anatomopathologie , Myocardite/immunologie , Inflammation/immunologieRÉSUMÉ
Skin lesions are frequently observed in children with rheumatic diseases, particularly in conditions such as IgA vasculitis (IgAV) and Kawasaki disease (KD). In paediatric vasculitis, the presence of skin lesions serves as an early indicator, emphasising the importance of timely diagnosis to prevent complications, such as cardiac or renal involvement. Conversely, autoinflammatory disorders like juvenile systemic lupus erythematosus (SLE) and juvenile dermatomyositis (DM) may manifest with cutaneous manifestations either at the onset of disease or during its progression. Identifying these skin lesions prior to the appearance of systemic symptoms offers an opportunity for early diagnosis and treatment, which has a positive influence on the outcomes. Additionally, it is noteworthy that specific rheumatological conditions, such as acute rheumatic fever (ARF) or oligoarticular or polyarticular forms of juvenile idiopathic arthritis (JIA), may exhibit occasional, but significant skin involvement, which is strongly correlated with an unfavourable prognosis. The assessment of skin is important in the holist approach to assessing patients for potentially systemic/multisystem disorder and helps distinguish discrete conditions.
Sujet(s)
Rhumatismes , Peau , Vascularite , Humains , Enfant , Rhumatismes/diagnostic , Rhumatismes/complications , Vascularite/étiologie , Vascularite/diagnostic , Peau/anatomopathologie , Maladie de Kawasaki/diagnosticRÉSUMÉ
OBJECTIVE: Systematic review of current evidence to analyze the prevalence of extracranial large vessel vasculitis (LVV) using 18F-FDG PET/CT in patients with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA). MATERIALS AND METHODS: PubMed and EMBASE were searched and the results were screened by two reviewers. Study quality was assessed using a modified version of the Newcastle-Ottawa scale. Heterogeneity between studies was assessed using the I2 statistic and the Q test. Further subgroup analyses were performed by disease type, study quality, and 18F-FDG PET/CT uptake criteria. Publication bias was assessed by funnel plot and Egger's test. RESULTS: 268 publications were identified, of which 17 met the selection criteria and were included in the meta-analysis. The overall pooled prevalence of extracranial LVV by 18F-FDG PET/CT was 54.5% [95% CI: 42.6%-66.1%]. In patients with GCA the prevalence was significantly higher than in patients with PMR (60.1% vs. 41.8%, Pâ¯=â¯0.006). Likewise, studies with a lower risk of bias reported a higher prevalence of extracranial LVV (61.1% vs. 46.9%; Pâ¯=â¯0.010). No publication bias was observed. CONCLUSIONS: The 18F-FDG PET/CT test may be useful in the detection of extracranial LVV, both in patients with PMR or GCA. Such involvement is more frequent in patients with GCA, and may vary depending on the quality of the studies.
Sujet(s)
Fluorodésoxyglucose F18 , Artérite à cellules géantes , Rhumatisme inflammatoire des ceintures , Tomographie par émission de positons couplée à la tomodensitométrie , Radiopharmaceutiques , Humains , Artérite à cellules géantes/imagerie diagnostique , Rhumatisme inflammatoire des ceintures/imagerie diagnostique , Vascularite/imagerie diagnostiqueRÉSUMÉ
BACKGROUND: The activation of innate immunity may be involved in the development of Candida albicans-induced murine vasculitis, which resembles Kawasaki disease (KD) vasculitis. This study aimed to histologically clarify the time course of the development of vasculitis in this model in detail and to estimate the potential role of spleen tyrosine kinase (Syk) inhibitors in KD vasculitis. METHODS AND RESULTS: DBA/2 male mice were intraperitoneally injected with a vasculitis-inducing substance and treated with a Syk inhibitor (R788 or GS-9973). Systemic vasculitis, especially in the aortic annulus area, was histologically evaluated. Regarding lesions in the aortic annulus area, some mice in the untreated control group already showed initiation of vasculitis 1 day after the final injection of a vasculitis-inducing substance. The vasculitis expanded over time. Inflammation occurred more frequently at the aortic root than at the coronary artery. The distribution of inflammatory cells was limited to the intima, intima plus adventitia, or all layers. In the Syk inhibitor-treated groups, only one mouse had vasculitis at all observation periods. The severity and area of the vasculitis were reduced by both Syk inhibitors. CONCLUSION: Candida albicans-induced murine vasculitis may occur within 1 day after the injection of a vasculitis-inducing substance. Additionally, Syk inhibitors suppress murine vasculitis.
Sujet(s)
Candida albicans , Modèles animaux de maladie humaine , Souris de lignée DBA , Inhibiteurs de protéines kinases , Syk kinase , Animaux , Syk kinase/antagonistes et inhibiteurs , Mâle , Inhibiteurs de protéines kinases/pharmacologie , Vascularite/anatomopathologie , Vascularite/traitement médicamenteux , Vascularite/induit chimiquement , Vascularite/microbiologie , Vascularite/enzymologie , Maladie de Kawasaki/traitement médicamenteux , Maladie de Kawasaki/anatomopathologie , Maladie de Kawasaki/enzymologie , Souris , Aorte/anatomopathologie , Aorte/effets des médicaments et des substances chimiques , Aorte/enzymologie , Facteurs temps , Candidose/traitement médicamenteux , Candidose/anatomopathologie , Candidose/microbiologie , Aminopyridines/pharmacologie , Nicotinamide/analogues et dérivés , PyrimidinesRÉSUMÉ
Urticarial vasculitis is a rare autoimmune disorder characterized by persistent edematous papules and plaques on the skin that last longer than 24 hours, often accompanied by systemic symptoms such as joint pain and fever. Unlike common urticaria, this condition involves inflammation of small blood vessels, leading to more severe and long-lasting skin lesions with a tendency to leave a bruiselike appearance. Diagnosis is challenging and may require a skin biopsy. Associated with underlying autoimmune diseases, treatment involves managing symptoms with medications such as antihistamines and corticosteroids, addressing the immune system's dysfunction, and treating any concurrent autoimmune conditions.
Sujet(s)
Urticaire , Vascularite , Humains , Urticaire/diagnostic , Urticaire/étiologie , Urticaire/immunologie , Vascularite/diagnostic , Peau/anatomopathologie , Peau/immunologie , Diagnostic différentiel , Antihistaminiques/usage thérapeutique , Maladies auto-immunes/diagnostic , Maladies auto-immunes/immunologie , Biopsie , Vascularite leucocytoclasique cutanée/diagnostic , Vascularite leucocytoclasique cutanée/immunologie , Vascularite leucocytoclasique cutanée/étiologieRÉSUMÉ
Systemic lupus erythematosus (SLE) is a complex autoimmune disease where the body loses tolerance to its own antigens, particularly nuclear antigens. Abnormal responses from T and B cells lead to the production of autoantibodies and the formation of immune complexes in tissues, triggering complement activation, inflammation, and irreversible organ damage. SLE can affect any part of the body, resulting in diverse clinical symptoms. One rare manifestation of SLE is lupus mesenteric vasculitis (LMV), which presents with vague symptoms, abnormal laboratory findings, and specific imaging features. LMV, although uncommon, can progress to severe complications such as bowel perforation, haemorrhage, and even mortality. Here, we report a case of LMV with the involvement of multiple organ systems (including mucocutaneous, musculoskeletal, serosal cavities, and haematological systems), presenting initially with life-threatening intractable gastrointestinal bleeding, and complicated by severe pulmonary infection. By sharing this case, we aim to enhance clinicians' confidence in managing critical SLE cases and raise awareness about disease surveillance.
Sujet(s)
Hémorragie gastro-intestinale , Lupus érythémateux disséminé , Vascularite , Humains , Hémorragie gastro-intestinale/étiologie , Lupus érythémateux disséminé/complications , Lupus érythémateux disséminé/diagnostic , Vascularite/diagnostic , Femelle , Mésentère , Tomodensitométrie , AdulteRÉSUMÉ
Vasculitic and pyoderma gangrenosum ulcers are traditionally treated with immunosuppressants, and the role of surgery in the treatment of these atypical ulcers remains unclear. This study aimed to investigate the need for surgical intervention as well as the outcome and safety of skin grafting in the treatment of 46 patients with vasculitic ulcers and 34 with pyoderma gangrenosum ulcers using data recorded in the validated Wound Registry. Of the 80 patients with atypical ulcers, 14% (n = 11) were treated surgically; these patients were older (p = 0.039), had lower mobility status (p = 0.002), and more often pulmonary diseases, rheumatoid arthritis, and previous arterial procedures (p = 0.007; p = 0.031; p = 0.031, respectively) than those treated conservatively. Of 181 ulcers, 15% (n = 27) were surgically treated, 78% once and 22% multiple times. During follow-up, 92.3% of both surgically and conservatively treated ulcers with available data healed. Of the surgically treated ulcers, median healing time after first surgical procedure was 96 days, and post-surgical complications were considered mild or unrelated to surgery. Our results suggest that if surgery is indicated, skin grafting is a safe and efficient treatment method provided that multidisciplinary approach is applied.
Sujet(s)
Pyodermie phadégénique , Transplantation de peau , Cicatrisation de plaie , Humains , Pyodermie phadégénique/chirurgie , Pyodermie phadégénique/thérapie , Mâle , Femelle , Transplantation de peau/méthodes , Adulte d'âge moyen , Sujet âgé , Adulte , Résultat thérapeutique , Sujet âgé de 80 ans ou plus , Études rétrospectives , Ulcère cutané/chirurgie , Ulcère cutané/thérapie , Vascularite/chirurgie , Vascularite/complicationsRÉSUMÉ
IgA nephropathy (IgAN) is a fairly common association with alcoholic liver disease. However, IgA vasculitis (IgAV) is quite an uncommon association with alcoholic liver cirrhosis and only a handful of cases have been reported in literature. Secondary IgAN usually presents in a docile manner, progressing slowly in about 5-25 years. It is usually responsive to steroid therapy, very rarely progressing to End-Stage Renal Disease. Here, we present a man in his late 50s, a known hypertensive and alcohol related liver-cirrhotic, who presented to our hospital with rash and rapidly progressive renal failure (RPRF). He was diagnosed with IgA nephritis with IgA vasculitis (IgAVN). His diagnosis was confirmed with skin and renal biopsy. He was started on renal replacement therapy for his renal failure and began oral steroid therapy. After administration of steroid therapy for 6 months, the patient recovered and was dialysis independent with stable renal parameters.
Sujet(s)
Glomérulonéphrite à dépôts d'IgA , Humains , Mâle , Glomérulonéphrite à dépôts d'IgA/complications , Glomérulonéphrite à dépôts d'IgA/diagnostic , Adulte d'âge moyen , Évolution de la maladie , Maladies alcooliques du foie/complications , /complications , /diagnostic , /traitement médicamenteux , Vascularite/complications , Vascularite/étiologie , Vascularite/diagnostic , Vascularite/traitement médicamenteuxRÉSUMÉ
A man in his 40s with end-stage kidney disease due to IgA nephropathy and receiving peritoneal dialysis presented with a 1-week history of breathlessness, cough and nosebleeds. CT scan of the chest revealed ground glass changes while blood tests indicated elevated inflammatory markers and a negative vasculitis screen. This included negative ANCA and anti-GBM antibodies. Initial treatment for suspected atypical pneumonia with antibiotics yielded no clinical improvement.Over the course of the admission, his symptoms progressively worsened, leading to oxygen dependency with a FiO2 of 40% and episodes of haemoptysis. Suspicions of pulmonary vasculitis arose due to clinical deterioration, prompting consultation with a tertiary vasculitis centre. It was subsequently concluded that the clinical and radiological findings correlated with ANCA-negative pulmonary vasculitis or a rare case of IgA-associated pulmonary capillaritis. Treatment with methylprednisolone and rituximab led to significant improvement, allowing rapid oxygen withdrawal. The patient was discharged with a tapering prednisolone regimen.